Levothyroxine Sodium Tablets recall — Class II (D-0290-2025) · pharmaranks
Class IIOngoing
Levothyroxine Sodium Tablets recall
FDA recall D-0290-2025 · initiated Mar 7, 2025
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Super-Potent Drug: Out of specification potency results were obtained.
Details
Product
Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-445-20.
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.